The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
Summary
Sixty-two (19.7%) patients reported themselves to be adherent to their medication.
Abstract
PURPOSE
(i) To evaluate the medication adherence rate of glaucoma patients in Singapore. (ii) To evaluate patients' quality of life status. (iii) To explore the factors related to patients' nonadherence to medication.
PATIENTS AND METHODS
A cross-sectional, prospective study, using interviewer-administered survey questionnaires. A total of 314 patients were interviewed altogether, of which 175 (55.7%) were male and 139 (44.3%) were female. (i) Patients' medication adherence was assessed using the Reported Adherence to Medication scale. (ii) Patients' beliefs about glaucoma and treatment were evaluated using the Brief Illness Perception Questionnaire and the Beliefs about Medicine-Specific Questionnaire. (iii) Patients' quality of life was evaluated using Glaucoma Symptom Scale and The Glaucoma Quality of Life-15 questionnaire.
RESULTS
Sixty-two (19.7%) patients reported themselves to be adherent to their medication. Male patients (P=0.044) and smokers (P=0.002) were more likely to be nonadherent to their medication regimen. Nonadherent patients were more likely to have (i) more concerns about their glaucoma medications (P=0.000); (ii) less belief in the effects of their medications (P=0.026); (iii) a lower quality of life (higher score of GQOL-15, P=0.014); (iv) less symptoms from their glaucoma (lower score of Glaucoma Symptom Scale, P=0.026); and (v) more effect on their lives from glaucoma (P=0.01).
CONCLUSIONS
The full-adherence rate is low among glaucoma patients. Having less belief in the need for and more concerns about their medication are the 2 factors associated with nonadherence. In the future, effective strategies should be explored to improve patients' beliefs. Nonadherence has an association with decreased quality of life. Strategies to improve adherence will need to deal with these areas.
More by Seng Chee Loon
View full profile →Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma.
Three-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma.
Efficacy and Safety of Repeated Micropulse Transscleral Diode Cyclophotocoagulation in Advanced Glaucoma.
Top Research in Quality of Life
Browse all →Neuroprotective strategies for retinal disease.
Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.
The Association Between Glaucoma, Anxiety, and Depression in a Large Population.
Discussion
Comments and discussion will appear here in a future update.